NEW YORK, NY / ACCESS Newswire / January 3, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Nektar Therapeutics ("Nektar" or the "Company") (NASDAQ:NKTR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Nektar and certain of its officers and/or directors have […]
NEW YORK, NY / ACCESS Newswire / January 3, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Anavex and certain of its officers and/or
NEW YORK, NY / ACCESS Newswire / January 3, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ:OM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Outset Medical and certain of its officers
NEW YORK CITY, NY / ACCESS Newswire / January 3, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Waldencast plc ("Waldencast" or the "Company") (NASDAQ:WALD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Waldencast and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / January 3, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Aerovironment, Inc. ("Aerovironment" or the "Company") (NASDAQ:AVAV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Aerovironment and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / January 3, 2026 / Pomerantz LLP is investigating claims on behalf of investors of RxSight, Inc. ("RxSight" or the "Company") (NASDAQ:RXST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether RxSight and certain of its officers and/or directors have
NEW YORK CITY, NY / ACCESS Newswire / January 3, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Graphic Packaging Holding Company ("Graphic Packaging" or the "Company") (NYSE:GPK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Graphic Packaging and certain of
NEW YORK CITY, NY / ACCESS Newswire / January 3, 2026 / Pomerantz LLP is investigating claims on behalf of investors of SCHMID Group N.V. ("Schmid" or the "Company") (NASDAQ:SHMD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Schmid and certain of its officers and/or
NEW YORK, NY / ACCESS Newswire / January 3, 2026 / Pomerantz LLP is investigating claims on behalf of investors of LENZ Therapeutics, Inc. ("LENZ" or the "Company") (NASDAQ:LENZ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether LENZ and certain of its officers and/or directors
New York City, Jan. 03, 2026 (GLOBE NEWSWIRE) — The online casino Ontario market has officially entered its most competitive and player-focused era. With regulation now firmly established and consumer protections stronger than ever, Ontario has become the benchmark province for legal online gambling in Canada. >>>Know More About Online Casino Ontario>>> As expectations rise,